The Journal of Experimental Medicine · 1993 · 241 citations · 23 references
HistocompatibilityAdaptive Immune SystemT-regulatory CellImmunologyDominant EpitopeAntigen ProcessingT CellsImmunotherapyCellular PhysiologyIndirect Recognition PathwaysCell TransplantationAllergyAutoimmune DiseaseAutoimmunitySelf-toleranceT Cell ImmunityHla-dr11/dr12 ResponderCell BiologyT Cell AlloreactivityCellular Immune ResponseMedicine
T cells from an HLA-DR11/DR12 responder were stimulated in mixed lymphocyte culture with cells carrying the DR1 antigen. After priming, T cells proliferated in response to both DR1-positive-stimulating cells and a peptide derived from a polymorphic region of the HLA-DR beta 1*0101 chain presented by responder's antigen-presenting cells (APC). The dominant epitope recognized by the primed T cells corresponded to residue 21-42 and was presented by the responder's HLA-DR12 antigen. The DR1 peptide-reactive T cells express T cell receptor V beta 3. The results demonstrate that allopeptides derived from the processing and presentation of donor major histocompatibility complex molecules by host-derived APC trigger alloreactivity. The frequency of T cells engaged in the indirect pathway of allorecognition is about 100-fold lower than that of T cells participating in the direct recognition of native HLA-DR antigen. However, indirect allorecognition may play an important role in chronic allograft rejection, a phenomenon that is mediated by the activation of T helper cells and of alloantibody-producing B cells.
23
Gilles Bénichou, Peter A. Takizawa, C A Olson et al. · The Journal of Experimental Medicine · 1992 · 271 citations · Full text
Alexander Y. Rudensky, Satyajit Rath, Paula Preston‐Hurlburt et al. · Nature · 1991 · 258 citations
Engineering, Complexity Science, Computational Complexity +3